<VariationArchive VariationID="1330798" VariationName="NM_005902.4(SMAD3):c.445_455del (p.Glu149fs)" VariationType="Deletion" Accession="VCV001330798" Version="10" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2022-01-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1321476" VariationID="1330798">
      <GeneList>
        <Gene Symbol="SMAD3" FullName="SMAD family member 3" GeneID="4088" HGNC_ID="HGNC:6769" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="67065602" stop="67195169" display_start="67065602" display_stop="67195169" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="67358194" stop="67487532" display_start="67358194" display_stop="67487532" Strand="+" />
          </Location>
          <OMIM>603109</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD3">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_005902.4(SMAD3):c.445_455del (p.Glu149fs)</Name>
      <CanonicalSPDI>NC_000015.10:67165294:CCGAGTTCCCCCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="67165295" stop="67165305" display_start="67165295" display_stop="67165305" variantLength="11" positionVCF="67165294" referenceAlleleVCF="GCCGAGTTCCCC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="67457633" stop="67457643" display_start="67457633" display_stop="67457643" variantLength="11" positionVCF="67457632" referenceAlleleVCF="GCCGAGTTCCCC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E105fs</ProteinChange>
      <ProteinChange>E149fs</ProteinChange>
      <ProteinChange>E44fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.67165297_67165307del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.67165297_67165307del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.67457635_67457645del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.67457635_67457645del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005902.4" sequenceAccession="NM_005902" sequenceVersion="4" change="c.445_455del" MANESelect="true">
            <Expression>NM_005902.4:c.445_455del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005893.1" sequenceAccession="NP_005893" sequenceVersion="1" change="p.Glu149fs">
            <Expression>NP_005893.1:p.Glu149fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011990.1" sequenceAccession="NG_011990" sequenceVersion="1" change="g.104441_104451del">
            <Expression>NG_011990.1:g.104441_104451del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145102.2" sequenceAccession="NM_001145102" sequenceVersion="2" change="c.130_140del">
            <Expression>NM_001145102.2:c.130_140del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138574.1" sequenceAccession="NP_001138574" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001138574.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145103.2" sequenceAccession="NM_001145103" sequenceVersion="2" change="c.313_323del">
            <Expression>NM_001145103.2:c.313_323del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138575.1" sequenceAccession="NP_001138575" sequenceVersion="1" change="p.Glu105fs">
            <Expression>NP_001138575.1:p.Glu105fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2140294805" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005902.4(SMAD3):c.445_455del (p.Glu149fs) AND Aneurysm-osteoarthritis syndrome" Accession="RCV001802457" Version="7">
        <ClassifiedConditionList TraitSetID="7467">
          <ClassifiedCondition DB="MedGen" ID="C3151087">Aneurysm-osteoarthritis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005902.4(SMAD3):c.445_455del (p.Glu149fs) AND Familial thoracic aortic aneurysm and aortic dissection" Accession="RCV001869473" Version="3">
        <ClassifiedConditionList TraitSetID="7840">
          <ClassifiedCondition DB="MedGen" ID="C4707243">Familial thoracic aortic aneurysm and aortic dissection</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-13" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-01-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21778426</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24804794</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="7840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16634" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="MONDO:0019625" DB="MONDO" />
                <XRef ID="91387" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysms and dissections</ElementValue>
                <XRef ID="UWMG_7008129" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="Thoracic+Aortic+Aneurysms+and+Aortic+Dissections/9386" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TAAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2249" />
                <XRef ID="2249" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301299</ID>
                <ID Source="BookShelf">NBK1120</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <XRef ID="91387" DB="Orphanet" />
              <XRef ID="C4707243" DB="MedGen" />
              <XRef ID="MONDO:0019625" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS607086" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7467" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16102" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANEURYSMS-OSTEOARTHRITIS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LOEYS-DIETZ SYNDROME WITH OSTEOARTHRITIS</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Loeys-Dietz syndrome, type 1C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Loeys-Dietz syndrome 3</ElementValue>
                <XRef ID="Loeys-Dietz+syndrome%2C+type+1C/8764" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aneurysm-osteoarthritis syndrome</ElementValue>
                <XRef ID="MONDO:0013426" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LDS3</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMAD3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LDS1C</ElementValue>
                <XRef Type="MIM" ID="613795" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10997" />
                <XRef ID="10997" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.</Attribute>
                <XRef ID="NBK1133" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301312</ID>
                <ID Source="BookShelf">NBK1133</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="284984" DB="Orphanet" />
              <XRef ID="C3151087" DB="MedGen" />
              <XRef ID="MONDO:0013426" DB="MONDO" />
              <XRef Type="MIM" ID="613795" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4016500" SubmissionDate="2022-01-04" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="3221749|OMIM:613795" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002048540" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The SMAD3 c.445_455del, p.Glu149ThrfsTer13 variant, to our knowledge, is not reported in the medical literature or gene specific databases. This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by deleting 11 nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, several downstream truncating variants have been described in individuals with Loeys-Dietz syndrome and thoracic aortic disorder and are considered pathogenic (Hostetler 2019, Schepers 2018). Based on available information, this variant is considered to be likely pathogenic. References: Hostetler EM et al. SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium. J Med Genet. 2019 Apr;56(4):252-260. PMID: 30661052. Schepers D et al. A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3. Hum Mutat. 2018 May;39(5):621-634. PMID: 29392890.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ythvkvge/arup_molecular_germline_variant_investigation_process_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.67457635_67457645delGAGTTCCCCCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613795" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ARUP Molecular 2021</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4252740" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13775621|MedGen:CN118826" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002230964" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21778426</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24804794</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with SMAD3-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu149Thrfs*13) in the SMAD3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMAD3 are known to be pathogenic (PMID: 21778426, 24804794).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.67457633_67457643del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN118826" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4252740" TraitType="Disease" MappingType="XRef" MappingValue="CN118826" MappingRef="MedGen">
        <MedGen CUI="C4707243" Name="Familial thoracic aortic aneurysm and aortic dissection" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4016500" TraitType="Disease" MappingType="XRef" MappingValue="613795" MappingRef="OMIM">
        <MedGen CUI="C3151087" Name="Aneurysm-osteoarthritis syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

